1. Home
  2. ARBE vs CABA Comparison

ARBE vs CABA Comparison

Compare ARBE & CABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARBE
  • CABA
  • Stock Information
  • Founded
  • ARBE 2015
  • CABA 2017
  • Country
  • ARBE Israel
  • CABA United States
  • Employees
  • ARBE N/A
  • CABA N/A
  • Industry
  • ARBE EDP Services
  • CABA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ARBE Technology
  • CABA Health Care
  • Exchange
  • ARBE Nasdaq
  • CABA Nasdaq
  • Market Cap
  • ARBE 124.2M
  • CABA 118.8M
  • IPO Year
  • ARBE N/A
  • CABA 2019
  • Fundamental
  • Price
  • ARBE $1.04
  • CABA $1.17
  • Analyst Decision
  • ARBE Buy
  • CABA Strong Buy
  • Analyst Count
  • ARBE 2
  • CABA 10
  • Target Price
  • ARBE $1.75
  • CABA $24.80
  • AVG Volume (30 Days)
  • ARBE 3.1M
  • CABA 802.2K
  • Earning Date
  • ARBE 05-21-2025
  • CABA 05-14-2025
  • Dividend Yield
  • ARBE N/A
  • CABA N/A
  • EPS Growth
  • ARBE N/A
  • CABA N/A
  • EPS
  • ARBE N/A
  • CABA N/A
  • Revenue
  • ARBE $768,000.00
  • CABA N/A
  • Revenue This Year
  • ARBE $398.05
  • CABA N/A
  • Revenue Next Year
  • ARBE $366.67
  • CABA N/A
  • P/E Ratio
  • ARBE N/A
  • CABA N/A
  • Revenue Growth
  • ARBE N/A
  • CABA N/A
  • 52 Week Low
  • ARBE $0.97
  • CABA $1.16
  • 52 Week High
  • ARBE $5.09
  • CABA $19.04
  • Technical
  • Relative Strength Index (RSI)
  • ARBE 27.17
  • CABA 24.03
  • Support Level
  • ARBE $0.97
  • CABA $1.45
  • Resistance Level
  • ARBE $1.36
  • CABA $1.85
  • Average True Range (ATR)
  • ARBE 0.09
  • CABA 0.14
  • MACD
  • ARBE 0.02
  • CABA -0.03
  • Stochastic Oscillator
  • ARBE 13.42
  • CABA 1.78

About ARBE Arbe Robotics Ltd.

Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, USA, and others.

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies, and exploring their potential to provide a deep and durable, perhaps curative, treatment, for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) has the potential to be applied across a broad range of autoimmune diseases.

Share on Social Networks: